BNP Paribas Financial Markets
QNTM

BNP Paribas Financial Markets’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

BNP Paribas Financial Markets’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-700
Closed -$14.2K – 5821
2025
Q2 		$14.2K Buy
+700
New +$8.63K ﹤0.01% 4742

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CTC
Cetera Trust Company St. Paul, Minnesota $177M AUM 28.75% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BNP Paribas Financial Markets's QNTM Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2025, closing a stake of 700 shares — an estimated $14.2K sold.

BNP Paribas Financial Markets first reported a position in QNTM in Q2 2025 and held it in 1 quarter. The position peaked at $14.2K in Q2 2025. 17 funds tracked by Wall St. Rank hold QNTM as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 700 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2025, an estimated $14.2K.
  • BNP Paribas Financial Markets first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2025 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $14.2K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.